Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Mitchell, Allen | Person |
Why?
|
| Werler, Martha | Person |
Why?
|
| Clinician reviewers in birth defects surveillance programs: survey of the National Birth Defects Prevention Network. | Academic Article |
Why?
|
| Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study. | Academic Article |
Why?
|
| Sex ratios among infants with birth defects, National Birth Defects Prevention Study, 1997-2009. | Academic Article |
Why?
|
| Twinning and major birth defects, National Birth Defects Prevention Study, 1997-2007. | Academic Article |
Why?
|
| Hernandez-Diaz, Sonia | Person |
Why?
|
| Sorensen, Henrik | Person |
Why?
|
| Vinceti, Marco | Person |
Why?
|
| Huybrechts, Krista | Person |
Why?
|
| Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS). | Academic Article |
Why?
|
| Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: Featuring critical congenital heart defects targeted for pulse oximetry screening. | Academic Article |
Why?
|
| Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011. | Academic Article |
Why?
|
| Maternal butalbital use and selected defects in the national birth defects prevention study. | Academic Article |
Why?
|
| Application of data screening to drug exposure in large risk factor studies of birth defects. | Academic Article |
Why?
|